Renaissance Technologies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
145,374
+130,151
+855% +$2.91M ﹤0.01% 1973
2026
Q1
$400K Buy
15,223
+6,987
+85% +$879K ﹤0.01% 2692
2025
Q4
$2.04M Sell
8,236
-29,016
-78% -$6.62M ﹤0.01% 1848
2025
Q3
$7.84M Buy
37,252
+3,098
+9% +$546K 0.01% 1210
2025
Q2
$3.36M Buy
34,154
+14,540
+74% +$1.27M ﹤0.01% 1774
2025
Q1
$1.73M Sell
19,614
-1,792
-8% -$166K ﹤0.01% 2101
2024
Q4
$1.55M Sell
21,406
-404
-2% -$27.7K ﹤0.01% 2215
2024
Q3
$1.72M Sell
21,810
-3,773
-15% -$290K ﹤0.01% 2122
2024
Q2
$1.84M Buy
25,583
+17,188
+205% +$1.03M ﹤0.01% 1926
2024
Q1
$792K Sell
8,395
-4,068
-33% -$358K ﹤0.01% 2633
2023
Q4
$910K Buy
+12,463
New +$737K ﹤0.01% 2469
2022
Q4
– Sell
-448
Closed -$429K – 4219
2022
Q3
$429K Sell
448
-413
-48% -$410K ﹤0.01% 3017
2022
Q2
$577K Sell
861
-790
-48% -$490K ﹤0.01% 3074
2022
Q1
$1.15M Buy
1,651
+1,105
+202% +$853K ﹤0.01% 2647
2021
Q4
$494K Buy
+546
New +$519K ﹤0.01% 3080
2021
Q2
– Sell
-1,875
Closed -$1.39M – 3577
2021
Q1
$1.39M Sell
1,875
-410
-18% -$331K ﹤0.01% 2442
2020
Q4
$1.77M Sell
2,285
-1,910
-46% -$1.51M ﹤0.01% 2196
2020
Q3
$4.17M Sell
4,195
-350
-8% -$371K ﹤0.01% 1674
2020
Q2
$4.73M Buy
4,545
+3,327
+273% +$3.35M ﹤0.01% 1676
2020
Q1
$989K Buy
+1,218
New +$1.27M ﹤0.01% 2431

Other funds holding GOSS

Renaissance Technologies's GOSS Position: Q2 2026 in Review

Renaissance Technologies increased its Gossamer Bio (GOSS) stake by 855% in Q2 2026, buying an estimated $2.91M and bringing the position to 145,374 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Renaissance Technologies first reported a position in GOSS in Q1 2020 and has held it in 20 quarters since. The position peaked at $7.84M in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Renaissance Technologies held 145,374 shares of Gossamer Bio worth $1.91M as of Q2 2026.
  • Renaissance Technologies bought 130,151 Gossamer Bio shares in Q2 2026, an estimated $2.91M.
  • Gossamer Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1973 holding.
  • Renaissance Technologies first reported a position in Gossamer Bio in Q1 2020 and has held it in 20 quarters since.
  • Renaissance Technologies's Gossamer Bio position peaked at $7.84M in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.